Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects

Overview of attention for article published in Drug Design, Development and Therapy, April 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 63 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

The development and benefits of metformin in various diseases

Article in Frontiers of Medicine (June 2023)

Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry

Article in Journal of Pharmaceutical Sciences (February 2023)

Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects

Article in Drug Design Development and Therapy (December 2022)